What is it? · Minor natural constituent; enhanced products differ

What is 7-Hydroxymitragynine?

7-Hydroxymitragynine is a kratom-related alkaloid commonly shortened to 7-OH. It can occur at low levels in botanical material and is also formed during mitragynine metabolism. Products deliberately enriched with 7-OH belong in a different category from conventional kratom leaf.

7-Hydroxymitragynine7-OH; 7OH; 7-hydroxy

Category

Minor natural constituent; enhanced products differ

Also called

7-OH; 7OH; 7-hydroxy

Key distinction

Ingredient identity and manufacturing process matter more than a trade name.

Added or enhanced 7-OH: advised against.

FDA distinguishes concentrated 7-OH products from traditional kratom leaf and warns about opioid-related risks. Laboratory and metabolism findings do not make a retail product interchangeable with leaf. Review the exact formulation, concentration and ingredient identity.

From leaf to ingredient

Where does it come from?

The molecule's name alone does not describe how a retail product was made. Chemical conversion can produce 7-OH from mitragynine, and manufacturers can formulate products around added or elevated 7-OH. Calling the starting material botanical does not make the resulting preparation ordinary leaf.

Read the label

What makes it different?

Natural occurrence and deliberate concentration are separate questions. A whole-leaf product with its native constituent profile is different from a tablet, shot or other preparation designed around enhanced 7-OH. We advise against added or enhanced 7-OH products.

What is its legal status?

DEA's October 14 notice proposes federal control above specified concentration or ratio thresholds. November 13 was the earliest possible publication date, not an automatic effective date. No new 7-OH order was verified through November 17, 2026. State and local 7-OH restrictions remain separate.

Check federal, state and local law

Read the originals

Sources & further reading

Legal sources reviewed: November 17, 2026.

Responsible-use guidance covers interactions, dependence and other precautions.